We are evaluating a new treatment for patients with metastatic or unresectable non-small cell lung cancer and other solid tumors. The study aims to assess its safety and how well it is tolerated.
Health conditions and diseases that the clinical trial is designed to study and treat.
Non-small cell lung cancer (NSCLC) is a type of lung cancer that includes several subtypes and is characterized by uncontrolled cell growth in the lungs. It can occur in various stages, from early stage (stage 0) to advanced stages (stage IV), and may spread to other parts of the body.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.
